← SynDRA
ROSIPTOR
SynDRA canonical compound SYN0039177 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | INPP5D |
|---|
| Mechanism of action | SHIP1 phosphatase activator |
|---|
All known targets
Mechanisms of action (all sources)
- INPP5D ACTIVATOR
- Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1 activator
- SHIP1 phosphatase activator
- INPP5D AGONIST
Cross-references
Synonyms
- AQX-1125
- AQX-1125 free base
- AQX-108
- AQX-131
- AQX-132
- AQX-133
- AQX-134
- AQX-135
- AQX-140
- AQX-150
- SHIP agonists (cancer/inflammation), Aquinox
- AQX 1125
- 6R5034F862
- rosiptorum
- RefChem:930892
- Rosiptor [USAN]
- UNII-6R5034F862
- Rosiptor (USAN/INN)
- ROSIPTOR [INN]
- ROSIPTOR [WHO-DD]
- GTPL9249
- orb1296256
- SCHEMBL16055992
- AQX1125
- MDEJTPWQNNMAQF-BVMLLJBZSA-N
- MFCD31619271
- AC-30923
- DA-57524
- MS-24762
- HY-109011
- CS-0030509
- NS00073600
- D11275
- G16212
- F979758
- rosiptor (proposed INN)
- Rosiptor acetate (USAN)
- TQ0032L
Look up ROSIPTOR in the interactive SynDRA portal →